Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors

Published:2023-12 Issue:12 Volume:5 Page:100880
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Parlati Lucia^ORCID,Sakka Mehdi,Retbi Aurelia^ORCID,Bouam Samir,Hassani Lamia,Meritet Jean-François,Rufat Pierre,Bonnefont-Rousselot Dominique,Batista Rui^ORCID,Terris Benoit,Bellanger Agnès,Thabut Dominique,Vozy Aurore,Spano Jean-Philippe,Coriat Romain^ORCID,Goldwasser François,Aractingi Selim^ORCID,Sogni Philippe,Pol Stanislas,Mallet Vincent^ORCID,Alexandre Jérôme,Arrondeau Jennifer,Boudou-Rouquette Pascaline,De Percin Sixtine,Kramkimel Nora,Huillard Olivier,Chapron Jeanne,Deau-Fischer Benedicte,Brandely-Piat Marie-Laure,Damotte Diane,Lupo Audrey,Alifano Marco,Corouge Marion,Hollande Clémence,Fontaine Hélène,Mehiri Lorianne Lair,Pichard Anaïs Vallet,Tilleul Patrick

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference29 articles.

1. Cancer immunologists scoop medicine Nobel prize;Ledford;Nature,2018

2. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015

3. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma;Larkin;N Engl J Med,2019

4. Immune-mediated hepatitis induced by immune checkpoint inhibitors: current updates and future perspectives;Liu;Front Pharmacol,2022

5. Hepatotoxicity from immune checkpoint inhibitors: a systematic review and management recommendation;Peeraphatdit;Hepatology,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. irLI or not irLI: That is the question;Journal of Hepatology;2024-07